Jess S. Morgan & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Jess S. Morgan & Co's BMY Position: Q2 2021 in Review
Jess S. Morgan & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 53,024 shares — an estimated $3.35M sold.
Jess S. Morgan & Co first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $3.35M in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Jess S. Morgan & Co reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Jess S. Morgan & Co sold 53,024 Bristol-Myers Squibb shares in Q2 2021, an estimated $3.35M.
- Jess S. Morgan & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
- Jess S. Morgan & Co's Bristol-Myers Squibb position peaked at $3.35M in Q1 2021.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Jess S. Morgan & Co's 13F filing for Q2 2021, filed 30 Nov 2021.